Research Summary
Post-herpetic neuralgia (PHN) treatment involves addressing the persistent pain that can occur after a shingles (herpes zoster) outbreak. PHN is characterized by chronic pain in the affected nerve pathway, lasting for weeks, months, or even years after the shingles rash has healed. Treatment options for post-herpetic neuralgia aim to manage pain and improve the individual＇s quality of life. Medications such as anticonvulsants, tricyclic antidepressants, and topical agents like lidocaine patches may be prescribed to help alleviate pain. Nerve blocks or injections of corticosteroids can also be considered. Non-pharmacological approaches like physical therapy, transcutaneous electrical nerve stimulation (TENS), and counseling for coping strategies may complement medical interventions. The choice of treatment depends on the severity of the pain, the individual＇s overall health, and their response to specific therapies. Early and comprehensive management is essential to minimize the impact of post-herpetic neuralgia on daily functioning and well-being.
According to WENKH research statistics, the global Post Herpetic Neuralgia Treatment market size will reach 1,997.04 Million USD in 2025 and is projected to reach 2,724.99 Million USD by 2032, with a CAGR of 4.54% (2025-2032). Among them, the Asia-Pacific Post Herpetic Neuralgia Treatment market is undergoing rapid changes, reaching Million USD in 2025, accounting for approximately % of the global market share. It is projected to reach Million USD by 2032.
The Post Herpetic Neuralgia Treatment market has seen a notable shift driven by advancements in drug delivery technology and a growing emphasis on multimodal pain management. Traditional treatments such as tricyclic antidepressants and opioid analgesics are facing growing scrutiny due to concerns over long-term safety and dependency risks. In response, pharmaceutical developers are investing in more targeted and innovative formulations, including extended-release gabapentin and transdermal patches that offer localized relief with reduced systemic exposure.
Emerging therapies are increasingly integrating nanotechnology and gene-based approaches. Nanocarrier systems, for instance, enhance bioavailability and allow for more precise targeting of affected nerve regions, minimizing side effects while maintaining efficacy. Additionally, pipeline products exploring non-opioid mechanisms—such as sodium channel blockers and monoclonal antibodies—are gaining traction due to their promise in mitigating chronic neuropathic pain without contributing to opioid-related complications.
Competition within this sector is intensifying as both established pharmaceutical companies and biotech startups vie for differentiation through unique delivery mechanisms and combination therapies. Regulatory agencies, meanwhile, are gradually shifting towards a more supportive stance on breakthrough treatments, especially those demonstrating improved patient compliance and safety profiles. These factors collectively point to a market evolution where innovation is not limited to new molecular entities but extends across how existing therapies are administered and optimized for long-term management of post-herpetic neuralgia.
The global Post Herpetic Neuralgia Treatment market is highly competitive, with key market players including Pfizer, Arbor Pharma, Assertio Therapeutics, Teva Pharmaceutical, Teikoku Pharma, Endo Pharma, Mylan, Hengrui Medicine, etc. This report categorizes the competitive landscape of the global Post Herpetic Neuralgia Treatment market into three tiers based on annual revenue, with the top three market players holding approximately % of the total market share.
This report provides an in-depth analysis of the global Post Herpetic Neuralgia Treatment market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, sales revenue, and gross profit margin of major players in the global Post Herpetic Neuralgia Treatment industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different product segments of Post Herpetic Neuralgia Treatment and their downstream application fields.
In terms of data, this report includes a comprehensive time-series dataset. The historical data spans from 2020 to 2024, providing a solid foundation for analyzing past market trends. The year 2025 is used as a base year to accurately assess the current market landscape. Forecast data covers the period from 2026 to 2032, utilizing scientific analysis methods and models to offer forward-looking predictions and insights into the market's future development. This provides valuable reference information for industry participants and stakeholders.
The report covers countries including United States, China, Germany, Japan, France, South Korea, United Kingdom, India, Italy, Brazil, Mexico, Indonesia, Vietnam and South Africa. It particularly focuses on the sales revenue of Post Herpetic Neuralgia Treatment in these countries, as well as the product segmentation and downstream application market size of each country. The report provides an in-depth analysis of the regional distribution and future development trends of the Post Herpetic Neuralgia Treatment market. By considering local policies, this report evaluates the market prospects of Post Herpetic Neuralgia Treatment in each country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.
This report places a strong emphasis on data quality and reliability, utilizing diverse and extensive data sources to ensure the accuracy and validity of the information presented. Primary data collection involves multiple channels, including in-depth interviews with senior executives, industry experts, supply chain stakeholders, and end consumers. These interviews provide key insights into corporate strategic planning, industry policy interpretation, supply chain dynamics, and end-user experiences. Secondary data sources cover a wide range of authoritative statistics from government agencies, customs databases, industry associations, third-party paid databases, brokerage research reports, academic research findings, corporate annual reports, financial statements, real-time news updates, and relevant information from international organizations. These data sources serve as a solid foundation for verification and analysis.
Companies Covered
Pfizer
Arbor Pharma
Assertio Therapeutics
Teva Pharmaceutical
Teikoku Pharma
Endo Pharma
Mylan
Hengrui Medicine
Product Segment
Anticonvulsants
Skin Patch
Others
Product Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Chapter Scope
Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects
Chapter 2: Global Post Herpetic Neuralgia Treatment Industry Chain Analysis
Chapter 3: Global Post Herpetic Neuralgia Treatment Industry Environment Analysis and Porter's Five Forces Analysis
Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global Post Herpetic Neuralgia Treatment Market (Market Share, Product Revenue Comparison, Tier Division, Corporate Expansion and M&A Trends)
Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Specifications and Features, Product Revenue and Product Gross Profit Margin)
Chapter 6: Global Post Herpetic Neuralgia Treatment Market Analysis by Countries, Product Segment and Downstream Application
Chapter 7: United States Post Herpetic Neuralgia Treatment Market Size, Product Segment, Downstream Application Analysis
Chapter 8: China Post Herpetic Neuralgia Treatment Market Size, Product Segment, Downstream Application Analysis
Chapter 9: Germany Post Herpetic Neuralgia Treatment Market Size, Product Segment, Downstream Application Analysis
Chapter 10: Japan Post Herpetic Neuralgia Treatment Market Size, Product Segment, Downstream Application Analysis
Chapter 11: France Post Herpetic Neuralgia Treatment Market Size, Product Segment, Downstream Application Analysis
Chapter 12: South Korea Post Herpetic Neuralgia Treatment Market Size, Product Segment, Downstream Application Analysis
Chapter 13: United Kingdom Post Herpetic Neuralgia Treatment Market Size, Product Segment, Downstream Application Analysis
Chapter 14: India Post Herpetic Neuralgia Treatment Market Size, Product Segment, Downstream Application Analysis
Chapter 15: Italy Post Herpetic Neuralgia Treatment Market Size, Product Segment, Downstream Application Analysis
Chapter 16: Brazil Post Herpetic Neuralgia Treatment Market Size, Product Segment, Downstream Application Analysis
Chapter 17: Mexico Post Herpetic Neuralgia Treatment Market Size, Product Segment, Downstream Application Analysis
Chapter 18: Indonesia Post Herpetic Neuralgia Treatment Market Size, Product Segment, Downstream Application Analysis
Chapter 19: Vietnam Post Herpetic Neuralgia Treatment Market Size, Product Segment, Downstream Application Analysis
Chapter 20: South Africa Post Herpetic Neuralgia Treatment Market Size, Product Segment, Downstream Application Analysis
Chapter 21: Research Conclusion
Chapter 22: Methodology and Data Source
Purpose and Value of the Report
Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.
Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.
Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.
Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.
Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.
Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.
Table of Content
1 Post Herpetic Neuralgia Treatment Market Overview
1.1 Product Definition Introduction
1.2 Global Post Herpetic Neuralgia Treatment Market Size and Growth Forecast Analysis (2020-2032)
1.3 Post Herpetic Neuralgia Treatment Market Status and Development Prospects
1.3.1 Post Herpetic Neuralgia Treatment Market Status
1.3.2 Post Herpetic Neuralgia Treatment Industry Development Prospects
1.4 Post Herpetic Neuralgia Treatment Market Overview by Product Segment
1.4.1 Global Post Herpetic Neuralgia Treatment Market Size and Growth Forecast Analysis by Product Segment: 2020 VS 2025 VS 2032
1.4.2 Anticonvulsants
1.4.3 Skin Patch
1.4.4 Others
1.5 Post Herpetic Neuralgia Treatment Market Overview by Product Application
1.5.1 Global Post Herpetic Neuralgia Treatment Market Size and Growth Forecast Analysis by Product Application: 2020 VS 2025 VS 2032
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
2 Post Herpetic Neuralgia Treatment Industry Supply Chain Analysis
2.1 Post Herpetic Neuralgia Treatment Supply Chain
2.2 Post Herpetic Neuralgia Treatment Midstream Suppliers
2.3 Post Herpetic Neuralgia Treatment Downstream Customers
2.4 Post Herpetic Neuralgia Treatment Sales Channel Analysis
3 Post Herpetic Neuralgia Treatment Market Environment Analysis
3.1 Post Herpetic Neuralgia Treatment Industry Policy Analysis
3.2 Post Herpetic Neuralgia Treatment Emerging Technology Trends in the Industry
3.3 Post Herpetic Neuralgia Treatment Restraining Factors Analysis
3.4 Post Herpetic Neuralgia Treatment Market Porter's Five Forces Analysis
3.4.1 Competitive Rivalry
3.4.2 Threat of New Entrants
3.4.3 Bargaining Power of Suppliers
3.4.4 Bargaining Power of Buyers
3.4.5 Threat of Substitute Products or Services
4 Global Post Herpetic Neuralgia Treatment Market Players Competition Landscape
4.1 Global Post Herpetic Neuralgia Treatment Market Revenue by Key Players (2021-2025)
4.2 Global Post Herpetic Neuralgia Treatment Market Position by Key Players
4.3 Global Key Players Headquarter and Key Area Served
4.4 Global Post Herpetic Neuralgia Treatment Market Expansion and M&A Dynamic
5 In-depth Analysis of Key Players
5.1 Pfizer
5.1.1 Pfizer Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.1.2 Pfizer Post Herpetic Neuralgia Treatment Product Features
5.1.3 Pfizer Post Herpetic Neuralgia Treatment Product Revenue and Gross Margin Analysis (2021-2025)
5.2 Arbor Pharma
5.2.1 Arbor Pharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.2.2 Arbor Pharma Post Herpetic Neuralgia Treatment Product Features
5.2.3 Arbor Pharma Post Herpetic Neuralgia Treatment Product Revenue and Gross Margin Analysis (2021-2025)
5.3 Assertio Therapeutics
5.3.1 Assertio Therapeutics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.3.2 Assertio Therapeutics Post Herpetic Neuralgia Treatment Product Features
5.3.3 Assertio Therapeutics Post Herpetic Neuralgia Treatment Product Revenue and Gross Margin Analysis (2021-2025)
5.4 Teva Pharmaceutical
5.4.1 Teva Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.4.2 Teva Pharmaceutical Post Herpetic Neuralgia Treatment Product Features
5.4.3 Teva Pharmaceutical Post Herpetic Neuralgia Treatment Product Revenue and Gross Margin Analysis (2021-2025)
5.5 Teikoku Pharma
5.5.1 Teikoku Pharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.5.2 Teikoku Pharma Post Herpetic Neuralgia Treatment Product Features
5.5.3 Teikoku Pharma Post Herpetic Neuralgia Treatment Product Revenue and Gross Margin Analysis (2021-2025)
5.6 Endo Pharma
5.6.1 Endo Pharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.6.2 Endo Pharma Post Herpetic Neuralgia Treatment Product Features
5.6.3 Endo Pharma Post Herpetic Neuralgia Treatment Product Revenue and Gross Margin Analysis (2021-2025)
5.7 Mylan
5.7.1 Mylan Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.7.2 Mylan Post Herpetic Neuralgia Treatment Product Features
5.7.3 Mylan Post Herpetic Neuralgia Treatment Product Revenue and Gross Margin Analysis (2021-2025)
5.8 Hengrui Medicine
5.8.1 Hengrui Medicine Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.8.2 Hengrui Medicine Post Herpetic Neuralgia Treatment Product Features
5.8.3 Hengrui Medicine Post Herpetic Neuralgia Treatment Product Revenue and Gross Margin Analysis (2021-2025)
6 Global Post Herpetic Neuralgia Treatment Market Analysis by Countries, by Product Segment and Application
6.1 Global Post Herpetic Neuralgia Treatment Market Size and Growth Forecast by Countries: 2020 VS 2025 VS 2032
6.1.1 Global Post Herpetic Neuralgia Treatment Market Revenue by Countries (2020-2025)
6.1.2 Global Post Herpetic Neuralgia Treatment Market Revenue Forecast by Countries (2026-2032)
6.2 Global Post Herpetic Neuralgia Treatment Market Size by Product Segment (2020-2032)
6.3 Global Post Herpetic Neuralgia Treatment Market Size by Product Application (2020-2032)
7 United States Post Herpetic Neuralgia Treatment Market Analysis
7.1 United States Post Herpetic Neuralgia Treatment Market Prospects
7.2 United States Post Herpetic Neuralgia Treatment Market Size by Product Segment (2020-2032)
7.3 United States Post Herpetic Neuralgia Treatment Market Size by Product Application (2020-2032)
8 China Post Herpetic Neuralgia Treatment Market Analysis
8.1 China Post Herpetic Neuralgia Treatment Market Prospects
8.2 China Post Herpetic Neuralgia Treatment Market Size by Product Segment (2020-2032)
8.3 China Post Herpetic Neuralgia Treatment Market Size by Product Application (2020-2032)
9 Germany Post Herpetic Neuralgia Treatment Market Analysis
9.1 Germany Post Herpetic Neuralgia Treatment Market Prospects
9.2 Germany Post Herpetic Neuralgia Treatment Market Size by Product Segment (2020-2032)
9.3 Germany Post Herpetic Neuralgia Treatment Market Size by Product Application (2020-2032)
10 Japan Post Herpetic Neuralgia Treatment Market Analysis
10.1 Japan Post Herpetic Neuralgia Treatment Market Prospects
10.2 Japan Post Herpetic Neuralgia Treatment Market Size by Product Segment (2020-2032)
10.3 Japan Post Herpetic Neuralgia Treatment Market Size by Product Application (2020-2032)
11 France Post Herpetic Neuralgia Treatment Market Analysis
11.1 France Post Herpetic Neuralgia Treatment Market Prospects
11.2 France Post Herpetic Neuralgia Treatment Market Size by Product Segment (2020-2032)
11.3 France Post Herpetic Neuralgia Treatment Market Size by Product Application (2020-2032)
12 South Korea Post Herpetic Neuralgia Treatment Market Analysis
12.1 South Korea Post Herpetic Neuralgia Treatment Market Prospects
12.2 South Korea Post Herpetic Neuralgia Treatment Market Size by Product Segment (2020-2032)
12.3 South Korea Post Herpetic Neuralgia Treatment Market Size by Product Application (2020-2032)
13 United Kingdom Post Herpetic Neuralgia Treatment Market Analysis
13.1 United Kingdom Post Herpetic Neuralgia Treatment Market Prospects
13.2 United Kingdom Post Herpetic Neuralgia Treatment Market Size by Product Segment (2020-2032)
13.3 United Kingdom Post Herpetic Neuralgia Treatment Market Size by Product Application (2020-2032)
14 India Post Herpetic Neuralgia Treatment Market Analysis
14.1 India Post Herpetic Neuralgia Treatment Market Prospects
14.2 India Post Herpetic Neuralgia Treatment Market Size by Product Segment (2020-2032)
14.3 India Post Herpetic Neuralgia Treatment Market Size by Product Application (2020-2032)
15 Italy Post Herpetic Neuralgia Treatment Market Analysis
15.1 Italy Post Herpetic Neuralgia Treatment Market Prospects
15.2 Italy Post Herpetic Neuralgia Treatment Market Size by Product Segment (2020-2032)
15.3 Italy Post Herpetic Neuralgia Treatment Market Size by Product Application (2020-2032)
16 Brazil Post Herpetic Neuralgia Treatment Market Analysis
16.1 Brazil Post Herpetic Neuralgia Treatment Market Prospects
16.2 Brazil Post Herpetic Neuralgia Treatment Market Size by Product Segment (2020-2032)
16.3 Brazil Post Herpetic Neuralgia Treatment Market Size by Product Application (2020-2032)
17 Mexico Post Herpetic Neuralgia Treatment Market Analysis
17.1 Mexico Post Herpetic Neuralgia Treatment Market Prospects
17.2 Mexico Post Herpetic Neuralgia Treatment Market Size by Product Segment (2020-2032)
17.3 Mexico Post Herpetic Neuralgia Treatment Market Size by Product Application (2020-2032)
18 Indonesia Post Herpetic Neuralgia Treatment Market Analysis
18.1 Indonesia Post Herpetic Neuralgia Treatment Market Prospects
18.2 Indonesia Post Herpetic Neuralgia Treatment Market Size by Product Segment (2020-2032)
18.3 Indonesia Post Herpetic Neuralgia Treatment Market Size by Product Application (2020-2032)
19 Vietnam Post Herpetic Neuralgia Treatment Market Analysis
19.1 Vietnam Post Herpetic Neuralgia Treatment Market Prospects
19.2 Vietnam Post Herpetic Neuralgia Treatment Market Size by Product Segment (2020-2032)
19.3 Vietnam Post Herpetic Neuralgia Treatment Market Size by Product Application (2020-2032)
20 South Africa Post Herpetic Neuralgia Treatment Market Analysis
20.1 South Africa Post Herpetic Neuralgia Treatment Market Prospects
20.2 South Africa Post Herpetic Neuralgia Treatment Market Size by Product Segment (2020-2032)
20.3 South Africa Post Herpetic Neuralgia Treatment Market Size by Product Application (2020-2032)
21 Research Conclusion
22 Appendix
22.1 Methodology/Research Approach
22.2 Research Landscape
22.3 Research Benchmark and Hypothesis
22.4 Data Source
22.4.1 Primary Sources
22.4.2 Secondary Sources
22.5 Data Cross Validation
22.6 Disclaimer
Table 1：Global Post Herpetic Neuralgia Treatment Market Size and Growth Forecast Analysis by Product Segment (2020 VS 2025 VS 2032) & (Million USD)
Table 2：Global Post Herpetic Neuralgia Treatment Market Size and Growth Forecast Analysis by Product Application (2020 VS 2025 VS 2032) & (Million USD)
Table 3：Post Herpetic Neuralgia Treatment Downstream Customers List
Table 4：Post Herpetic Neuralgia Treatment Distributors/Dealers List
Table 5：Global Post Herpetic Neuralgia Treatment Market Revenue by Key Players (2021-2025) & (Million USD)
Table 6：Global Post Herpetic Neuralgia Treatment Market Position by Key Players
Table 7：Global Key Players Headquarter and Key Area Served
Table 8：Global Post Herpetic Neuralgia Treatment Market Expansion and M&A Dynamic
Table 9：Pfizer Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 10：Pfizer Post Herpetic Neuralgia Treatment Product Features
Table 11：Pfizer Post Herpetic Neuralgia Treatment Revenue (Million USD) and Gross Margin (2021-2025)
Table 12：Arbor Pharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 13：Arbor Pharma Post Herpetic Neuralgia Treatment Product Features
Table 14：Arbor Pharma Post Herpetic Neuralgia Treatment Revenue (Million USD) and Gross Margin (2021-2025)
Table 15：Assertio Therapeutics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 16：Assertio Therapeutics Post Herpetic Neuralgia Treatment Product Features
Table 17：Assertio Therapeutics Post Herpetic Neuralgia Treatment Revenue (Million USD) and Gross Margin (2021-2025)
Table 18：Teva Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 19：Teva Pharmaceutical Post Herpetic Neuralgia Treatment Product Features
Table 20：Teva Pharmaceutical Post Herpetic Neuralgia Treatment Revenue (Million USD) and Gross Margin (2021-2025)
Table 21：Teikoku Pharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 22：Teikoku Pharma Post Herpetic Neuralgia Treatment Product Features
Table 23：Teikoku Pharma Post Herpetic Neuralgia Treatment Revenue (Million USD) and Gross Margin (2021-2025)
Table 24：Endo Pharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 25：Endo Pharma Post Herpetic Neuralgia Treatment Product Features
Table 26：Endo Pharma Post Herpetic Neuralgia Treatment Revenue (Million USD) and Gross Margin (2021-2025)
Table 27：Mylan Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 28：Mylan Post Herpetic Neuralgia Treatment Product Features
Table 29：Mylan Post Herpetic Neuralgia Treatment Revenue (Million USD) and Gross Margin (2021-2025)
Table 30：Hengrui Medicine Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 31：Hengrui Medicine Post Herpetic Neuralgia Treatment Product Features
Table 32：Hengrui Medicine Post Herpetic Neuralgia Treatment Revenue (Million USD) and Gross Margin (2021-2025)
Table 33：Global Post Herpetic Neuralgia Treatment Market Size and Growth Forecast by Countries (2020 VS 2025 VS 2032) & (Million USD)
Table 34：Global Post Herpetic Neuralgia Treatment Market Revenue by Countries (2020-2025) & (Million USD)
Table 35：Global Post Herpetic Neuralgia Treatment Market Share by Countries (2020-2025)
Table 36：Global Post Herpetic Neuralgia Treatment Market Revenue Forecast by Countries (2026-2032) & (Million USD)
Table 37：Global Post Herpetic Neuralgia Treatment Market Share Forecast by Countries (2026-2032)
Table 38：Global Post Herpetic Neuralgia Treatment Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 39：Global Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 40：Global Post Herpetic Neuralgia Treatment Market Revenue by Product Application (2020-2025) & (Million USD)
Table 41：Global Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 42：United States Post Herpetic Neuralgia Treatment Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 43：United States Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 44：United States Post Herpetic Neuralgia Treatment Market Revenue by Product Application (2020-2025) & (Million USD)
Table 45：United States Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 46：China Post Herpetic Neuralgia Treatment Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 47：China Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 48：China Post Herpetic Neuralgia Treatment Market Revenue by Product Application (2020-2025) & (Million USD)
Table 49：China Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 50：Germany Post Herpetic Neuralgia Treatment Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 51：Germany Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 52：Germany Post Herpetic Neuralgia Treatment Market Revenue by Product Application (2020-2025) & (Million USD)
Table 53：Germany Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 54：Japan Post Herpetic Neuralgia Treatment Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 55：Japan Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 56：Japan Post Herpetic Neuralgia Treatment Market Revenue by Product Application (2020-2025) & (Million USD)
Table 57：Japan Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 58：France Post Herpetic Neuralgia Treatment Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 59：France Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 60：France Post Herpetic Neuralgia Treatment Market Revenue by Product Application (2020-2025) & (Million USD)
Table 61：France Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 62：South Korea Post Herpetic Neuralgia Treatment Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 63：South Korea Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 64：South Korea Post Herpetic Neuralgia Treatment Market Revenue by Product Application (2020-2025) & (Million USD)
Table 65：South Korea Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 66：United Kingdom Post Herpetic Neuralgia Treatment Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 67：United Kingdom Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 68：United Kingdom Post Herpetic Neuralgia Treatment Market Revenue by Product Application (2020-2025) & (Million USD)
Table 69：United Kingdom Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 70：India Post Herpetic Neuralgia Treatment Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 71：India Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 72：India Post Herpetic Neuralgia Treatment Market Revenue by Product Application (2020-2025) & (Million USD)
Table 73：India Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 74：Italy Post Herpetic Neuralgia Treatment Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 75：Italy Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 76：Italy Post Herpetic Neuralgia Treatment Market Revenue by Product Application (2020-2025) & (Million USD)
Table 77：Italy Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 78：Brazil Post Herpetic Neuralgia Treatment Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 79：Brazil Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 80：Brazil Post Herpetic Neuralgia Treatment Market Revenue by Product Application (2020-2025) & (Million USD)
Table 81：Brazil Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 82：Mexico Post Herpetic Neuralgia Treatment Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 83：Mexico Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 84：Mexico Post Herpetic Neuralgia Treatment Market Revenue by Product Application (2020-2025) & (Million USD)
Table 85：Mexico Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 86：Indonesia Post Herpetic Neuralgia Treatment Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 87：Indonesia Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 88：Indonesia Post Herpetic Neuralgia Treatment Market Revenue by Product Application (2020-2025) & (Million USD)
Table 89：Indonesia Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 90：Vietnam Post Herpetic Neuralgia Treatment Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 91：Vietnam Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 92：Vietnam Post Herpetic Neuralgia Treatment Market Revenue by Product Application (2020-2025) & (Million USD)
Table 93：Vietnam Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 94：South Africa Post Herpetic Neuralgia Treatment Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 95：South Africa Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 96：South Africa Post Herpetic Neuralgia Treatment Market Revenue by Product Application (2020-2025) & (Million USD)
Table 97：South Africa Post Herpetic Neuralgia Treatment Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 98：Secondary Sources
Figure 1：Post Herpetic Neuralgia Treatment Product Scope
Figure 2：Global Post Herpetic Neuralgia Treatment Market Size and Growth Forecast Analysis (2020-2032) & (Million USD)
Figure 3：Global Post Herpetic Neuralgia Treatment Product Segment Market Share (2025 & 2032)
Figure 4：Global Post Herpetic Neuralgia Treatment Product Application Market Share (2025 & 2032)
Figure 5：Anticonvulsants Product Scope
Figure 6：Skin Patch Product Scope
Figure 7：Others Product Scope
Figure 8：Hospital Pharmacies Product Scope
Figure 9：Online Pharmacies Product Scope
Figure 10：Retail Pharmacies Product Scope
Figure 11：Post Herpetic Neuralgia Treatment Industrial Chain Framework
Figure 12：Global Post Herpetic Neuralgia Treatment Market by Geographic Segmentation in 2025
Figure 13：Global Post Herpetic Neuralgia Treatment Market Share by Countries (2020 VS 2025)
Figure 14：United States Post Herpetic Neuralgia Treatment Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 15：China Post Herpetic Neuralgia Treatment Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 16：Germany Post Herpetic Neuralgia Treatment Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 17：Japan Post Herpetic Neuralgia Treatment Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 18：France Post Herpetic Neuralgia Treatment Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 19：South Korea Post Herpetic Neuralgia Treatment Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 20：United Kingdom Post Herpetic Neuralgia Treatment Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 21：India Post Herpetic Neuralgia Treatment Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 22：Italy Post Herpetic Neuralgia Treatment Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 23：Brazil Post Herpetic Neuralgia Treatment Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 24：Mexico Post Herpetic Neuralgia Treatment Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 25：Indonesia Post Herpetic Neuralgia Treatment Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 26：Vietnam Post Herpetic Neuralgia Treatment Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 27：South Africa Post Herpetic Neuralgia Treatment Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 28：Research Methodology
Figure 29：Primary Sources
Figure 30：Data Cross Validation
Global Post Herpetic Neuralgia Treatment Revenue and Market Share by Key Players
| Revenue (US$ Million) | 2020 | 2021 | 2022 | 2023 | 2024 |
| Pfizer | XX | XX | XX | XX | XX |
| Arbor Pharma | XX | XX | XX | XX | XX |
| Assertio Therapeutics | XX | XX | XX | XX | XX |
| Teva Pharmaceutical | XX | XX | XX | XX | XX |
| Teikoku Pharma | XX | XX | XX | XX | XX |
| Endo Pharma | XX | XX | XX | XX | XX |
| Mylan | XX | XX | XX | XX | XX |
| Hengrui Medicine | XX | XX | XX | XX | XX |
| Other Companies | XX | XX | XX | XX | XX |
| Total | XX | XX | XX | XX | XX |
English
Related Reports 
